Cardiovascular Disease Prevention and Control

Cardiovascular disease prevention and control covers the population- and individual-level strategies used to reduce the incidence, recurrence, and burden of heart and blood-vessel disease. It centres on modifiable risk factors such as tobacco use, high blood pressure, dyslipidaemia, diabetes, poor diet, and physical inactivity, and on the concept of cardiovascular health as a positive, measurable state rather than only the absence of disease.

Definition

Cardiovascular disease prevention and control is the set of activities aimed at lowering the occurrence and progression of cardiovascular disease by modifying risk factors and promoting cardiovascular health across populations and individuals.

Scope

This topic describes how cardiovascular risk is conceptualized, estimated, and reduced in community and public health nursing practice: risk-factor identification, global risk estimation, the distinction between primary and secondary prevention, and population approaches to cardiovascular health. It is a reference entry on the structure of prevention and does not provide individual diagnostic thresholds or treatment regimens.

Core questions

• Which risk factors most strongly drive cardiovascular disease, and which are modifiable?
• How is overall cardiovascular risk estimated rather than assessed factor by factor?
• How does primary prevention differ from secondary prevention after an event?
• What population-level measures support cardiovascular health?

Key concepts

• Modifiable cardiovascular risk factors
• Global (multifactorial) risk estimation
• Cardiovascular health as a positive construct
• Primary versus secondary prevention
• Population-wide versus high-risk strategies
• Blood pressure and lipid control
• Tobacco cessation

Mechanisms

Cardiovascular risk is multifactorial: tobacco use, raised blood pressure, abnormal lipids, diabetes, abdominal obesity, poor diet, physical inactivity, and psychosocial stress each contribute, and large studies such as INTERHEART suggest a small number of modifiable factors account for much of the population risk of myocardial infarction. Because factors combine, risk is best estimated globally rather than one factor at a time, an approach pioneered by Framingham-based risk functions that translate risk-factor profiles into an estimated probability of an event. Prevention then works at two levels: a population strategy that shifts the whole distribution of risk factors downward, and a high-risk strategy that targets those at greatest estimated risk. Frameworks such as the American Heart Association's cardiovascular-health construct reframe the goal as building and preserving health metrics rather than only treating established disease.

Clinical relevance

Cardiovascular disease is a leading cause of death globally, and nurses contribute to risk assessment, counselling, screening, and supporting risk-factor control across community and primary-care settings. This entry explains how prevention is structured at the population and program level and is educational reference material; it does not set individual targets or prescribe therapy.

Epidemiology

Cardiovascular diseases are among the leading causes of death worldwide and a central component of the noncommunicable disease burden addressed by the WHO global action plan. A substantial share of this burden is attributable to modifiable risk factors, which underpins the rationale for prevention at both population and individual levels.

History

Systematic cardiovascular prevention grew out of the Framingham Heart Study, which identified the major risk factors and gave rise to multivariable risk functions in the 1990s. International case-control work such as INTERHEART later quantified the contribution of modifiable factors across diverse populations, and contemporary frameworks reframed cardiovascular health as a positive, measurable construct to be promoted from early life.

Debates

Population-wide versus high-risk prevention strategies

Whether prevention is better served by shifting risk-factor distributions across the whole population or by targeting individuals at high estimated risk remains a long-standing strategic debate, with most frameworks combining both.

Key figures

• William B. Kannel
• Peter W. F. Wilson
• Salim Yusuf
• David M. Lloyd-Jones

Seminal works

• wilson-1998
• yusuf-2004
• lloyd-jones-2022

Frequently asked questions

Why is cardiovascular risk estimated using a combination of factors?

Because risk factors act together rather than in isolation, combining them into a single global estimate predicts the likelihood of an event more accurately than considering any one factor alone.

What is the difference between primary and secondary prevention of cardiovascular disease?

Primary prevention aims to stop a first cardiovascular event by controlling risk factors before disease develops, while secondary prevention aims to reduce recurrence and progression in people who already have established disease.